My HPRA: Register

IMATINIB

100 Milligram Capsules Hard

Cipla (EU) LimitedPA1809/017/001

Main Information

Trade NameIMATINIB
Active SubstancesIMATINIB MESILATE
Strength100 Milligram
Dosage FormCapsules Hard
Licence HolderCipla (EU) Limited
Licence NumberPA1809/017/001

Group Information

ATC CodeL01X OTHER CYTOSTATICS

Status

Authorised/WithdrawnAuthorised
Licence Issued07/08/2015
Supply StatusSupply through pharmacies only
Dispensing StatusProduct subject to prescription which may not be renewed (A)
Marketing StatusNot Marketed
Promotion StatusPromotion to Healthcare Professionals only
Conditions of LicenceMedicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back
Follow medicine

Print

Summary of Product Characteristics

View More SPC Headings

Latest Changes to Medicine Info & SPC

View all available

Please note changes to the medicine information and summary of product characteristics are only available from the 19/05/2015 onwards. Changes made before this date aren't available online.